Insider · CIK 0001926535
Sirshendu Roopom Banerjee
Files at CMRA (Comera Life Sciences Holdings, Inc.). First filing -, latest -.
In brief
Sirshendu Roopom Banerjee files SEC Form 4 as director at CMRA (Comera Life Sciences Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sirshendu Roopom Banerjee has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 9, 2023 | CMRA Comera Life Sciences Holdings, Inc. | AGrant or award Stock Option (Right to Purchase)derivative | +122,487 | $0.00 | $0 | 122,487 | Nov 14, 2023 |
Questions about Sirshendu Roopom Banerjee
Answered from the filings on this page, as of the latest one.
Is Sirshendu Roopom Banerjee buying or selling?
Sirshendu Roopom Banerjee has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sirshendu Roopom Banerjee's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sirshendu Roopom Banerjee has 0.
Where does Sirshendu Roopom Banerjee file Form 4?
Sirshendu Roopom Banerjee has filed Form 4 at CMRA (Comera Life Sciences Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.